Norethisterone/testosterone-cipionate: Prostatic and pilar metaplasia: 20 case reports.

This report describes the 17-year-old female to male transgender patient (patient no. 4 from table 1 of the article): The patient underwent nipple-sparing mastectomy and received treatment with testosterone cipionate for 33 months. This report describes the 18-year-old female to male transgender patient (patient no. 14 from table 1 of the article): The patient underwent nipple-sparing mastectomy and received treatment with testosterone cipionate for 34 months. This report describes the 16-year-old female to male transgender patient (patient no. 3 from table 1 of the article): The patient underwent nipple-sparing mastectomy and received treatment with testosterone cipionate for 18 months. This report describes the 18-year-old female to male transgender patient (patient no. 12 from table 1 of the article): The patient underwent nipple-sparing mastectomy and received treatment with testosterone cipionate for 27 months. [Extracted from the article]